Trident Texofab (BOM:540726) Asset Turnover: 0.30 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:540726 Trident Texofab Ltd BOM:540726
64 GF Score
Price ₹32.33
GF Value ₹63.36
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Trident Texofab Asset Turnover?

Trident Texofab BOM:540726 +2.83% 64 Asset Turnover is 0.30 as of Mar. 2026. GuruFocus rates BOM:540726 with a GF Score™ of 64/100 and a GF Value™ of ₹63.36 (Possible Value Trap). The stock has 7 warning signs investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Trident Texofab's Revenue for the three months ended in Mar. 2026 was ₹336 Mil. Trident Texofab's Total Assets for the quarter that ended in Mar. 2026 was ₹1,112 Mil. Therefore, Trident Texofab's Asset Turnover for the quarter that ended in Mar. 2026 was 0.30.

Asset Turnover is linked to ROE % through Du Pont Formula. Trident Texofab's annualized ROE % for the quarter that ended in Mar. 2026 was -14.46%. It is also linked to ROA % through Du Pont Formula. Trident Texofab's annualized ROA % for the quarter that ended in Mar. 2026 was -7.23%.


Trident Texofab  (BOM:540726) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Trident Texofab's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-80.376/555.823
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-80.376 / 1342.808)*(1342.808 / 1111.568)*(1111.568/ 555.823)
=Net Margin %*Asset Turnover*Equity Multiplier
=-5.99 %*1.208*1.9999
=ROA %*Equity Multiplier
=-7.23 %*1.9999
=-14.46 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Trident Texofab's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=-80.376/1111.568
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-80.376 / 1342.808)*(1342.808 / 1111.568)
=Net Margin %*Asset Turnover
=-5.99 %*1.208
=-7.23 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Trident Texofab Asset Turnover Related Terms


Trident Texofab Asset Turnover Historical Data

* Premium members only.

The historical data trend for Trident Texofab's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trident Texofab Asset Turnover Chart

Trident Texofab Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.22 1.30 1.25 1.34 1.12

Trident Texofab Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.38 0.28 0.27 0.23 0.30

Trident Texofab Asset Turnover Competitor Comparison

For the Textile Manufacturing subindustry, Trident Texofab's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trident Texofab Asset Turnover vs Manufacturing - Apparel & Accessories Industry

For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Trident Texofab's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Trident Texofab's Asset Turnover falls into.


BOM:540726
64GF Score
Trident Texofab Ltd BOM:540726
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Trident Texofab Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Trident Texofab's Asset Turnover for the fiscal year that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Mar. 2026 )/( (Total Assets (A: Mar. 2025 )+Total Assets (A: Mar. 2026 ))/ count )
=1180.225/( (1005.756+1111.568)/ 2 )
=1180.225/1058.662
=1.11

Trident Texofab's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=335.702/( (0+1111.568)/ 1 )
=335.702/1111.568
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.30 mean?
Trident Texofab (BOM:540726) has a Asset Turnover of 0.30 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Trident Texofab and its competitors.
Is Trident Texofab's Asset Turnover too high?
Trident Texofab's current Asset Turnover is 0.30. Overall, Trident Texofab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Texofab's Asset Turnover compare to competitors?
Trident Texofab's Asset Turnover of 0.30 can be compared against companies in the Manufacturing - Apparel & Accessories industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Manufacturing - Apparel & Accessories company?
A good Asset Turnover depends on the Manufacturing - Apparel & Accessories industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Trident Texofab and its competitors. Trident Texofab's current Asset Turnover is 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Texofab stock overvalued right now?
Based on GuruFocus' analysis, Trident Texofab (BOM:540726) is currently considered Possible Value Trap. The stock's GF Value™ is ₹63.36, compared to a current price of ₹32.33 — trading 49% below its estimated fair value. The current Asset Turnover is 0.30. Trident Texofab's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Trident Texofab (BOM:540726), the current Asset Turnover is 0.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Trident Texofab (BOM:540726) Overvalued in 2026?

Based on GuruFocus' analysis, Trident Texofab stock appears to be undervalued. The current stock price of ₹32.33 is trading 49% below its estimated GF Value™ of ₹63.36. GuruFocus considers Trident Texofab to be Possible Value Trap.

Key valuation signals for BOM:540726:

  • Asset Turnover: 0.30
  • GF Value™: ₹63.36 vs. price of ₹32.33 (49% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the BOM:540726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Trident Texofab Business Description

Address Ring Road, Nodh-4/1650, Sahara Darwaja, 2004, 2nd Floor, North Extension, Falsawadi, Begumpura, Surat, GJ, IND, 395003
Trident Texofab Ltd is a multi-product fabric trading company. The company is engaged in the business of manufacturing & Wholesale Trading of Textile Fabric Cloth. Its brands are Storia Of Shed, Light Trail, Comfy Zoi, and Alicon. The company's products offering includes curtains, shower curtains, cushion covers, pillows and Bed sheets. It operates through the Textile Fabric Cloth segment.
64GF Score

Get the complete analysis for BOM:540726

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹32.33
Price
₹63.36
GF Value